Abstract
Purpose
To evaluate the clinical effectiveness of a newly designed stent for the treatment of malignant distal duodenal stenosis.
Methods
From March 2011 to May 2013, six patients with malignant duodenal stenosis underwent fluoroscopically guided placement of the new duodenal stent consisting of braided, nested stent wires, and a delivery system with a metallic mesh inner layer. Primary diseases were pancreatic cancer in three patients, gastric cancer in two patients, and endometrial stromal sarcoma in one patient. Duodenal obstructions were located in the horizontal part in two patients, the ascending part in two patients, and the duodenojejunal flexure in two patients. Technical success, defined as the successful stent deployment, clinical symptoms before and after the procedure, and complications were evaluated.
Results
Technical success was achieved in all patients. No major complications were observed. Before treatment, two patients could not take any food and the gastric outlet obstruction scoring system (GOOSS) score was 0; the other four patients could take only liquids orally (GOOSS score = 1). After treatment, five patients could take soft food (GOOSS score = 2) and one patient could take a full diet (GOOSS score = 3). The mean duration of primary stent patency was 115.7 days.
Conclusions
The newly designed stent is associated with a high degree of technical success and good clinical outcome and may be clinically effective in the management of malignant distal duodenal obstruction.
Similar content being viewed by others
References
Weaver DW, Wiencek RG, Bouwman DL, Walt AJ (1987) Gastrojejunostomy: is it helpful for patients with pancreatic cancer? Surgery 102(4):608–613
van Wagensveld BA, Coene PP, van Gulik TM et al (1997) Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg 84(10):1402–1406. PMID: 9361599
Lillemoe KD, Cameron JL, Hardacre JM et al (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230(3):322–328
Isla AM, Worthington T, Kakkar AK, Williamson RC (2000) A continuing role for surgical bypass in the palliative treatment of pancreatic carcinoma. Dig Surg 17(2):143–146
Choi YB (2002) Laparoscopic gastrojejunostomy for palliation of gastric outlet obstruction in unresectable gastric cancer. Surg Endosc 16(11):1620–1626
Johnsson E, Thune A, Liedman B (2004) Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg 28(8):812–817
Mittal A, Windsor J, Woodfield J, Casey P, Lane M (2004) Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg 91(2):205–209
Maetani I, Akatsuka S, Ikeda M et al (2005) Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy. J Gastroenterol 40(10):932–937
Fiori E, Lamazza A, Volpino P et al (2004) Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res 24(1):269–271
Pinto IT (1997) Malignant gastric and duodenal stenosis: palliation by peroral implantation of a self-expanding metallic stent. Cardiovasc Interv Radiol 20(6):431–434
Gutzeit A, Binkert CA, Schoch E, Sautter T, Jost R, Zollikofer CL (2009) Malignant gastroduodenal obstruction: treatment with self-expanding uncovered wallstent. Cardiovasc Interv Radiol 32(1):97–105
Kim JH, Song HY, Shin JH et al (2007) Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 66(2):256–264
Brimhall B, Adler DG (2011) Enteral stents for malignant gastric outlet obstruction. Gastrointest Endosc Clin N Am 21(3):389–403
Woo SM, Kim DH, Lee WJ et al (2013) Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer. Surg Endosc 27(6):2031–2039
Jeurnink SM, Repici A, Luigiano C, Pagano N, Kuipers EJ, Siersema PD (2009) Use of a colonoscope for distal duodenal stent placement in patients with malignant obstruction. Surg Endosc 23(3):562–567
Adler DG, Baron TH (2002) Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 97(1):72–78
Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, p 196
Baron TH, Harewood GC (2003) Enteral self-expandable stents. Gastrointest Endosc 58(3):421–433
Kim CG, Choi IJ, Lee JY et al (2010) Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc 72(1):25–32
Telford JJ, Carr-Locke DL, Baron TH et al (2004) Palliation of patients with malignant gastric outlet obstruction with the enteral wallstent: outcomes from a multicenter study. Gastrointest Endosc 60(6):916–920
Sasaki T, Isayama H, Maetani I et al (2013) Japanese multicenter estimation of WallFlex duodenal stent for unresectable malignant gastric outlet obstruction. Dig Endosc 25(1):1–6
Conflict of interest
Wei-Zhong Zhou, Zheng-Qiang Yang, Sheng Liu, Chun-Gao Zhou, Jin-Guo Xia, Lin-Bo Zhao, and Hai-Bin Shi declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, WZ., Yang, ZQ., Liu, S. et al. A Newly Designed Stent for Management of Malignant Distal Duodenal Stenosis. Cardiovasc Intervent Radiol 38, 177–181 (2015). https://doi.org/10.1007/s00270-014-0899-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-014-0899-9